However, while the oncoprotein became undetectable in the menin-inhibitor-treated AML, the oncogene was still expressed, but at lower levels, as confirmed by reverse transcription PCR using two different primer sets (Fig. 7c). Here, MEN1 is linked to acute myeloid leukemia.